Zhao, Tian Xiao https://orcid.org/0000-0003-0202-5255
Kostapanos, Michalis
Griffiths, Charmaine
Arbon, Emma L
Hubsch, Annette
Kaloyirou, Fotini
Helmy, Joanna
Hoole, Stephen P
Rudd, James H F
Wood, Graham
Burling, Keith
Bond, Simon
Cheriyan, Joseph
Mallat, Ziad
Clinical trials referenced in this document:
Documents that mention this clinical trial
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial (Pre-results)
https://doi.org/10.1136/bmjopen-2018-022452
Documents that mention this clinical trial
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial (Pre-results)
https://doi.org/10.1136/bmjopen-2018-022452
Funding for this research was provided by:
Medical Research Council